DEFINITY

This brand name is authorized in United States. It is also authorized in Canada, New Zealand.

Active ingredients

The drug DEFINITY contains one active pharmaceutical ingredient (API):

1	Perflutren UNII CK0N3WH0SR - PERFLUTREN
	When used in conjunction with diagnostic ultrasound, perflutren provides opacification of cardiac chambers, improvement in delineation of endocardial borders, enhancement of the Doppler signal, and visualisation of wall motion and blood flow within the heart.
	Read more about Perflutren

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DEFINITY Suspension for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V08DA04		V Various → V08 Contrast media → V08D Ultrasound contrast media → V08DA Ultrasound contrast media
Discover more medicines within V08DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02243173
NZ	Medicines and Medical Devices Safety Authority	13174
US	FDA, National Drug Code	11994-011, 11994-017